238 related articles for article (PubMed ID: 8209014)
1. Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization.
Angeli E; Carpanelli R; Crespi G; Zanello A; Sironi S; Del Maschio A
Radiol Med; 1994 May; 87(5 Suppl 1):24-31. PubMed ID: 8209014
[TBL] [Abstract][Full Text] [Related]
2. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
[TBL] [Abstract][Full Text] [Related]
3. Color Doppler imaging of liver metastases. The value phase-III of a US contrast agent: SH U 508 A (Levovist) Schering.
Campani R; Bozzini A; Calliada F; Bottinelli O; Anguissola R; Conti MP; Corsi G
Radiol Med; 1994 May; 87(5 Suppl 1):32-40. PubMed ID: 8209016
[TBL] [Abstract][Full Text] [Related]
4. [The correlation between Doppler echography with a contrast medium and CT in the study of a hepatocarcinoma submitted to chemoembolization].
Catalano O; Cusati B; Esposito M; Trivellini V; Lobianco R; Siani A
Radiol Med; 1998 Jun; 95(6):608-13. PubMed ID: 9717543
[TBL] [Abstract][Full Text] [Related]
5. Enhanced color flows in hepatic tumors.
Yang CC; Chen CH; Yeh YH
Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound contrast agent Levovist in colour Doppler sonography of hepatocellular carcinoma in Chinese patients.
Khong PL; Chau MT; Fan ST; Leong LL
Australas Radiol; 1999 May; 43(2):156-9. PubMed ID: 10901894
[TBL] [Abstract][Full Text] [Related]
7. [Role of color Doppler ultrasonography with contrast media in the monitoring of hepatocarcinoma after intralesional treatment].
Pennisi F; Farina R; Ponzio R; Fragione D; Lombardo R; Azzarello G; Puleo S
Radiol Med; 1999 Mar; 97(3):144-7. PubMed ID: 10363055
[TBL] [Abstract][Full Text] [Related]
8. [Enhanced color flow findings in small hepatocellular carcinoma].
Maruyama H; Matsutani S; Ebara M; Saisho H
Nihon Rinsho; 1998 Apr; 56(4):967-74. PubMed ID: 9577618
[TBL] [Abstract][Full Text] [Related]
9. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
[TBL] [Abstract][Full Text] [Related]
10. Feasibility study of an ultrasound contrast agent (levovist) in color Doppler imaging of liver neoplasms.
Jiang Y; Dai Q; Liu J; Zhang J; Chang X; Cai S; Tan L
Chin Med Sci J; 1999 Sep; 14(3):167-9. PubMed ID: 12903818
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: therapeutic experience with percutaneous ethanol injection under real-time contrast-enhanced color Doppler sonography with the contrast agent Levovist.
Shirato K; Morimoto M; Tomita N; Kokawa A; Sugimori K; Saito T; Numata K; Sekihara H; Tanaka K
J Ultrasound Med; 2002 Sep; 21(9):1015-22. PubMed ID: 12216749
[TBL] [Abstract][Full Text] [Related]
12. Color Doppler ultrasonography in the differential diagnosis of focal hepatic lesions. The SH U 508 A (Levovist) experience.
Maresca G; Barbaro B; Summaria V; De Gaetano AM; Salcuni M; Mirk P; Marano P
Radiol Med; 1994 May; 87(5 Suppl 1):41-9. PubMed ID: 8209017
[TBL] [Abstract][Full Text] [Related]
13. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
[TBL] [Abstract][Full Text] [Related]
15. Enhanced color flow images in small hepatocellular carcinoma.
Maruyama H; Matsutani S; Sato G; Nakano Y; Mitsuhashi O; Yoshikawa M; Ebara M; Saisho H; Ohto M
Abdom Imaging; 2000; 25(2):164-71. PubMed ID: 10675459
[TBL] [Abstract][Full Text] [Related]
16. Color Doppler flow imaging of renal disease. Value of a new intravenous contrast agent: SH U 508 A (Levovist).
Filippone A; Muzi M; Basilico R; Di Giandomenico V; Trapani AR; Bonomo L
Radiol Med; 1994 May; 87(5 Suppl 1):50-8. PubMed ID: 8209018
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US.
Bartolozzi C; Lencioni R; Ricci P; Paolicchi A; Rossi P; Passariello R
Radiology; 1998 Nov; 209(2):387-93. PubMed ID: 9807563
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of blood flows inside hepatic tumors using color Doppler echography with galactose-based intravenous contrast medium "SH/TA 508" administration].
Ishii M; Kawauchi A; Sakamoto M; Sasaki K; Kumano Y; Nishida H; Mukai T; Kusano M
Nihon Rinsho; 1998 Apr; 56(4):975-9. PubMed ID: 9577619
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma treated with chemoembolization: assessment with contrast-enhanced doppler ultrasonography.
Catalano O; Esposito M; Lobianco R; Cusati B; Altei F; Siani A
Cardiovasc Intervent Radiol; 1999; 22(6):486-92. PubMed ID: 10556408
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.
Kim AY; Choi BI; Kim TK; Han JK; Yun EJ; Lee KY; Han MC
Radiology; 1998 Oct; 209(1):135-40. PubMed ID: 9769824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
